Noncompetitive inhibitors do not target the active site; instead, they bind to an allosteric site, which is a different location on the enzyme molecule.
Binding at the allosteric site causes a conformational change (a change in shape) in the enzyme's tertiary structure. This distortion alters the shape of the active site so that it is no longer compatible with the substrate.
Unlike competitive inhibition, adding more substrate does not overcome the effect of a noncompetitive inhibitor because the substrate and inhibitor are not competing for the same
Reversible inhibitors typically bind to the enzyme via weak, non-covalent interactions such as hydrogen bonds or ionic attractions. These inhibitors can detach, allowing the enzyme to regain its function.
Irreversible inhibitors form strong covalent bonds with the enzyme, often at the active site. This creates a permanent change that effectively 'kills' the enzyme molecule, as the inhibitor cannot be removed through physiological means.
Irreversible inhibition is often used by toxins and certain heavy metals, while reversible inhibition is a common feature of metabolic control and drug design.
| Feature | Competitive Inhibition | Noncompetitive Inhibition |
|---|---|---|
| Binding Site | Active Site | Allosteric Site |
| Inhibitor Shape | Similar to substrate | Different from substrate |
| Effect of Substrate | Can overcome inhibition | Cannot overcome inhibition |
| Maximal Rate () | Can still be reached | Is permanently lowered |
| Mechanism | Physical blocking | Conformational change |
Graph Interpretation: On a reaction rate vs. substrate concentration graph, look at the plateau. If the curve eventually reaches the same height as the uninhibited reaction, it is competitive. If the plateau is lower, it is noncompetitive.
Initial Rate vs. Max Rate: Always distinguish between the initial rate of reaction and the maximal rate. Both types of inhibition lower the initial rate, but only noncompetitive inhibition lowers the maximal rate regardless of substrate levels.
Terminology Check: Ensure you use the term allosteric site when discussing noncompetitive inhibition and complementary shape when discussing why competitive inhibitors fit into active sites.